Issuer · CIK 0002020932

AGMB — AgomAb Therapeutics NV

Recent filings

Nov 6, 2026·Form 4·Pro · in 21h 52m$•••K
AGMB/AgomAb Therapeutics NV
Epstein David R · director
Proonly

← Back to all filings